Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545 (CP145)

This study has been completed.
Information provided by (Responsible Party):
MedImmune LLC Identifier:
First received: May 11, 2007
Last updated: November 16, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)